ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
125.970,46
-0,13%
S&P 500
5.994,57
-0,76%
US Dollar vs BRL
5,8084
0,01%
Bitcoin
100.843,21
-0,57%
Brent Oil
75,435
0,10%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Reino Unido
  5. LSE
  6. Hutchmed (china) Limited (HCM)

  7. Hutchmed (china) Limited (HCM) Notícias

HCM

Hutchmed (china) (HCM)

Hutchmed (china) Limited
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:HCM
DataHoraFonteTítuloCódigoCompanhia
28/01/202506:00RNS Regulatory NewsHutchmed (China) Limited Overseas Regulatory AnnouncementLSE:HCMHutchmed (china) Limited
14/01/202509:07Alliance NewsAlliance NewsIN BRIEF: Hutchmed lung cancer treatment Orpathys approved in ChinaLSE:HCMHutchmed (china) Limited
14/01/202504:00RNS Non-RegulatoryHutchmed (China) Limited Full Approval for ORPATHYS in ChinaLSE:HCMHutchmed (china) Limited
02/01/202507:46Alliance NewsAlliance NewsHutchmed China disposes of 45% stake in Shanghai joint ventureLSE:HCMHutchmed (china) Limited
02/01/202504:01RNS Non-RegulatoryHutchmed (China) Limited China NDA Acceptance for ORPATHYS and TAGRISSOLSE:HCMHutchmed (china) Limited
02/01/202504:00RNS Regulatory NewsHutchmed (China) Limited US$608m Divestment of Non-Core Joint VentureLSE:HCMHutchmed (china) Limited
31/12/202405:30RNS Regulatory NewsHutchmed (China) Limited Appointment of Joint Corporate BrokerLSE:HCMHutchmed (china) Limited
30/12/202405:30RNS Regulatory NewsHutchmed (China) Limited Blocklisting Six Monthly ReturnLSE:HCMHutchmed (china) Limited
13/12/202407:04Alliance NewsAlliance NewsIN BRIEF: Hutchmed to get Takeda milestone paymentLSE:HCMHutchmed (china) Limited
13/12/202404:00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED to Receive Milestone Payment from TakedaLSE:HCMHutchmed (china) Limited
12/12/202404:00RNS Non-RegulatoryHutchmed (China) Limited Breakthrough Therapy Designation in ChinaLSE:HCMHutchmed (china) Limited
03/12/202409:19Alliance NewsAlliance NewsHutchmed China injection approval could be a "paradigm shift"LSE:HCMHutchmed (china) Limited
03/12/202407:00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED and Innovent Announce ELUNATE ApprovalLSE:HCMHutchmed (china) Limited
29/11/202405:30RNS Regulatory NewsHutchmed (China) Limited Total Voting RightsLSE:HCMHutchmed (china) Limited
28/11/202407:32RNS Non-RegulatoryHutchmed (China) Limited Continued Inclusion of ORPATHYS in China NRDLLSE:HCMHutchmed (china) Limited
22/11/202407:00Alliance NewsAlliance NewsHutchmed to get payment from Takeda as Fruzaqla launched in JapanLSE:HCMHutchmed (china) Limited
22/11/202404:00RNS Non-RegulatoryHutchmed (China) Limited FRUZAQLA® Launched in Japan by TakedaLSE:HCMHutchmed (china) Limited
20/11/202406:30RNS Regulatory NewsHutchmed (China) Limited Appointment of Independent Non-executive DirectorLSE:HCMHutchmed (china) Limited
06/11/202404:00RNS Non-RegulatoryHutchmed (China) Limited Clinical Data to be Presented at ASH and ESMO AsiaLSE:HCMHutchmed (china) Limited
31/10/202409:02Alliance NewsAlliance NewsHutchmed China receives first milestone payment for Takeda drug salesLSE:HCMHutchmed (china) Limited
31/10/202405:30RNS Non-RegulatoryHutchmed (China) Limited First Commercial Milestone PaymentLSE:HCMHutchmed (china) Limited
21/10/202405:30RNS Regulatory NewsHutchmed (China) Limited Vesting of awards under the LTIPLSE:HCMHutchmed (china) Limited
16/10/202405:52Alliance NewsAlliance NewsTOP NEWS: AstraZeneca's Tagrisso plus Orpathys shows promising resultsLSE:HCMHutchmed (china) Limited
16/10/202403:00RNS Regulatory NewsHutchmed (China) Limited SAVANNAH: clinically meaningful response rateLSE:HCMHutchmed (china) Limited
24/09/202404:49Alliance NewsAlliance NewsTakeda Pharmaceutical says Fruzaqla cancer drug gets Japan backingLSE:HCMHutchmed (china) Limited
24/09/202404:00RNS Regulatory NewsHutchmed (China) Limited Japan Approval for FRUZAQLALSE:HCMHutchmed (china) Limited
09/09/202403:00RNS Non-RegulatoryHutchmed (China) Limited Clinical Data to be Presented at ESMO and WCLCLSE:HCMHutchmed (china) Limited
30/08/202408:24Alliance NewsAlliance NewsHutchmed "disappointed" as it withdraws fruquintinib applicationLSE:HCMHutchmed (china) Limited
30/08/202403:00RNS Regulatory NewsHutchmed (China) Limited Update on Fruquintinib for Gastric Cancer in ChinaLSE:HCMHutchmed (china) Limited
22/08/202405:30RNS Regulatory NewsHutchmed (China) Limited Standard form for notification of major holdingsLSE:HCMHutchmed (china) Limited
 Apresentando as notícias mais relevantes sobre:LSE:HCM

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
FNAM11
Fundo Invest Amazonia Fi...
BOV
AGXY3
Agrogalaxy Participacoes ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios